ARTICLE | Clinical News
Fc-EDA1 regulatory update
June 18, 2012 7:00 AM UTC
FDA granted Fast Track designation for Edimer's EDI200 to treat X-linked hypohidrotic ectodermal dysplasia (XLHED). EDI200 is a recombinant protein comprised of the Fc domain of human IgG1 and tumor...